<p>Philip J. Shaw of Thailand's National Center for Genetic Engineering and Biotechnology will seek to identify potential drug targets and vaccine antigens in the malaria parasite using a novel technology to reduce specific gene expression. By fusing a natural genetic "riboswitch" onto gene targets, the team will attempt to attenuate gene expression and thereby determine gene function.</p>


Philip J. Shaw of Thailand's National Center for Genetic Engineering and Biotechnology will seek to identify potential drug targets and vaccine antigens in the malaria parasite using a novel technology to reduce specific gene expression. By fusing a natural genetic "riboswitch" onto gene targets, the team will attempt to attenuate gene expression and thereby determine gene function.